CORPORATE PROFILE: A Clinical Trial/ Life Sciences technology startup with 7 employees and $2M revenue goal. RESPONSIBILITY PROFILE: Reporting to the Chairman as a member of the Advisory Board, responsible for defining strategic direction, leading business and organizational development, market analysis, go-to-market strategy, and product development planning.

CORPORATE PROFILE: A $420M Clinical Trial/ Life Sciences technology company with 2,000 employees. RESPONSIBILITY PROFILE: I reported to the COO with a $1.5M OPEX and 12 employees with 3 direct. I was responsible for organizational transformation, recruiting and building teams, implementing a risk mitigation plan, and reducing overall attrition.ACHIEVED IN THIS ROLEORGANIZATIONAL DEVELOPMENT• In the aftermath of a significant merger, the organization struggled to establish unified teams, cultures, and operations, resulting in substantial setbacks. I was recruited by the COO to increase productivity and efficiency, lower attrition rates, and hit desired revenue targets. Over seven months, I spearheaded an organizational transformation that included a top-down business process re-engineering effort, resulting in a new org. structure that harmonized all functions to increase efficiency and productivity. I orchestrated the acquisition of a CRO partner’s RTSM business. I was responsible for implementing a risk mitigation plan to ensure business continuity and led effort to transition legacy studies. This improved the culture, leading to ~ $2M in prevented revenue loss and an additional ~$1M in work rewarded.CUSTOMER RECOVERY• Performance and customer relations after the integration of a recent merger, led to key client and revenue losses. I worked to revive customer engagement and restore growth, improved metrics, KPIs, and instituted a new change management program. This restored productivity, customer engagement, and a long-term portfolio growth of ~10-20% within 90 days. As a result, renewal of partnerships with clients was restored, leading to the retention of existing portfolios and the restoration of preferred vendor status.

CORPORATE PROFILE: A Management Consulting firm working with Pharma/Clinical Trial technology companies. RESPONSIBILITY PROFILE: I collaborated with pharma and biotech companies to implement eClinical strategies and organizational optimization. Evaluation of an EDC (Electronic Data Capture) company for a VC firm for potential acquisition; development of an eClinical acquisition strategy and infrastructure development for a VC firm to introduce a new differentiated, competitive offering to the market; development of a new supply chain organizational structure and optimization strategy for clinical supply chain operations for a pharma company; various engagements to evaluate and recommend eClinical vendors for selection as the preferred vendor.

CORPORATE PROFILE: A $22M Deeptech company with 219 employees. RESPONSIBILITY PROFILE: I reported to the CEO with a $4M OPEX, $8M Revenue Goal, and 15 employees with 2 direct. I was responsible for transforming business performance, growing the organization, and establishing a presence among the NA market and clients. I successfully transitioned operations to Cambridge from NJ; grew the organization by over 100% to meet new client growth demands; increased NA revenue by >75%; revamped operational and client engagement and governance processes to increase productivity and client retention.• Within a year, I exceeded an aggressive growth target, revitalized North America business, and grew U.S. revenue 100%+ YoY.• To capitalize on growth opportunities, I led a strategic pivot, new long-term vision, organizational restructuring, and revamped product roadmap.• I improved efficiency, service, client retention, and profitability through an increased industry and client presence achieved through an office relocation and client engagement.• For optimal business governance, I worked with the CEO and Board on problem-solving and organizational alignment.• I earned leadership buy-in for a new, comprehensive business plan to seize new market and partnership opportunities.

Providing management consulting and advisory services for Life Sciences. Focused speciality areas include eClinical, Randomization and Trial Supply Management, development operations and organizational development.

CORPORATE PROFILE: A $1.4B eClinical technology company with 5,000 employees.Managing Director, Medical & Commercial Imaging (2016 - 2018) RESPONSIBILITY PROFILE: I reported to the COO with a $5M OPEX, $2M CAPEX, $22M Revenue Goal, and 150 employees with 7 direct. I was responsible for developing integration plans for all aspects of the business, increasing market share, reducing client attrition, and growing existing client footprints.ACHIEVED IN THIS ROLEMERGERS & ACQUISITIONS• I was tasked by the COO to lead the successful merger of a newly acquired company specializing in medical imaging into Medidata’s eClinical platform. I developed a business plan and, over the following 6 months, evaluated employees, met with key clients, and integrated/harmonized the organizational structure, development, testing, support processes, and systems. The team successfully met all initial objectives and was enabled to attract new customers and a ~$2M in increased revenue, ultimately leading to a more competitive platform and stable client base.

RESPONSIBILITY PROFILE: I was promoted to rejuvenate RTSM business line, infuse strategic direction, advance service delivery, and halt client attrition. I worked with the GM of Sales to define sales targets, forecast revenue, and contribute insights to the Scientific Advisory Board.ACHIEVED IN THIS ROLEBUSINESS TRANSFORMATION• I was promoted by the COO to resolve the loss of customers to competitors as the RTSM business line was underperforming. Led customer engagement, process analysis, and budget evaluation. Within a year’s time, the business was stabilized, morale improved, employee attrition was reduced, and revenue increased. I was promoted to head of Medical & Commercial Imaging in addition to RTSM responsibilities; received the 2016 Presidents Club award.STRATEGIC PARTNERSHIPS• I was appointed to handle the high costs of clinical drug supply and global shipping for a key biotech oncology program. Drug pooling was proposed to run multiple protocols simultaneously across five indications, leading to a fast-tracked timeline for approval. Within 4 months, changed product roadmap, reallocated resources, and completed market analysis. As a result, drug supply costs were reduced by 30%, and shipping costs were reduced by 40%, providing fuel for new investment. Was recognized with the Medidata's President's Club award for outstanding achievement and the 2017 CARE award for industry partnership.MARKET PENETRATION• The organization's system was tailored exclusively to serve the Biotech and Pharma industry until an opportunity to penetrate the medical device sector presented itself. Given medical device trials and regulatory requirements were notably different, and only a handful of providers monopolized the market, a complete overhaul was needed. I led market/landscape analyses, gap assessments, and secured resources and budget. Delivered the pilot protocol for a new customer and a ~$1M revenue stream in the first year.

As the co-founder of the company’s strategic consulting group, I directed high-level engagements to optimize clients’ complex supply chain operations, remote-based monitoring, and study protocol design.• I sharpened the competitive edge, increased the ROI, and produced consistent 7-figure annual revenue.• Working with client senior management, I helped pioneer new eClinical strategies to capitalize on emerging market opportunities and minimize non value-add activities.

CORPORATE PROFILE: A $64B Management Consulting Life Sciences company with 740,000 employees. RESPONSIBILITY PROFILE: I reported to the Partner of Life Sciences with 250 employees with 5 direct. I was responsible for providing program and project management oversight of 40+ projects as part of the planning, design, and implementation processes.ACHIEVED IN THIS ROLETEAM LEADERSHIP / COACHING• Upon joining the organization, I was tasked by the Managing Director to build a substantial onshore and offshore team and deliver critical components. After three months of assessing business objectives, bid strategy, and functional requirements, I created a comprehensive plan based on an evaluated budget. This established a highly functional and fully aligned team, leading to successful bid wins of ~$100M, lucrative partnerships, and increased revenue. Received Accenture 2012 People Developer Award.

CORPORATE PROFILE: A $3.8B Clinical Research organization with 18,000 employees. RESPONSIBILITY PROFILE: I reported to the President with a $4M OPEX, $40M Revenue Goal, and 28 employees with 3 direct. I was responsible for establishing a governance model between research services and technology subsidiaries, facilitating improved client relationships and implementations. Introduced new KPIs and metrics to measure partnership effectiveness.ACHIEVED IN THIS ROLEATTRITION REVERSAL• I was recruited by the President after three years of low morale and high attrition complicated customer engagement. Working with customers and management, I built and introduced a new model to address friction points in development, deployment, and support processes. This increase in productivity of ~20% and client satisfaction eventually reduced attrition rates below the industry average and boosted the company's reputation as an attractive workplace.

Director, Development Informatics, 2004-2007 │ Program Manager, 2001-2004CORPORATE PROFILE: A $70B Drug Development company with 83,000 employees. RESPONSIBILITY PROFILE: I reported to the Senior Director with a $1M OPEX, $4M CAPEX, and 40 employees with 5 direct. I was responsible for creating an internal RTSM capability for the industry’s first web-based randomization and drug supply management system and transforming the clinical data management environment to reduce required resources significantly.Top achievements at Pfizer included:• Driving the build and scaling of the industry’s first web-based solution for randomizing patients and managing drug supply, saving tens of millions of dollars.• Boosting drug manufacturing capacity through a robust finite capacity planning system.• Shrinking data reconciliation time 90%, cutting costs, and accelerating decisions by developing internal reporting for clinical trial operations.